MEI Pharma, Inc. 是一家從事藥品化合物開發的製藥公司。公司總部位於美國加州聖地牙哥,目前聘有28名全職員工。該公司在2003年12月18日上市。該公司的資金計畫以萊特幣為基礎。公司已終止voruciclib的臨床開發,但與其候選藥物資產相關的某些非臨床活動仍在繼續進行。作為戰略選擇評估的一部分,公司可能會考慮現有項目的外部授權機會以及合併與收購機會。
MEIP stock price ended at $0 on 星期六, after dropping NaN%
On the latest trading day May 30, 2026, the stock price of MEIP fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for MEIP decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.